Cablevisión Holding announces its Full Year and Fourth Quarter 2020 Results (FY20 and 4Q20)
BUENOS AIRES, ARGENTINA / ACCESSWIRE / March 10, 2021 / Cablevisión Holding S.A., (“Cablevision Holding”,…
BUENOS AIRES, ARGENTINA / ACCESSWIRE / March 10, 2021 / Cablevisión Holding S.A., (“Cablevision Holding”,…
VANCOUVER, BC / ACCESSWIRE / March 10, 2021 / Success manifests itself in different ways….
Growth returns with record fourth quarter revenue of $13.7 million, up 52% vs. third quarter…
Mollie reveals the state of payments across retail in Europe Amsterdam and London, 11 March…
JSC Olainfarm has been invited to participate in building a vaccine manufacturing plant in Latvia…
For patients living in areas with limited healthcare resources, WHO prequalification ensures access to the…
The REMDACTA clinical trial of Actemra/RoActemra plus Veklury did not meet its primary endpoint of…
Strong cash and cash equivalents position at Dec 31, 2020 of $20.2M (CHF18.7M) Balance sheet…
Legally required documents for shareholders’ votes are available on Biophytis website PARIS and CAMBRIDGE, Mass.,…
– Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85%…
Phase 3 data comparing tebentafusp (IMCgp100) with investigator’s choice subject of oral plenary OXFORDSHIRE, England…
GUANGZHOU, China, March 10, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
Media Release Copenhagen, Denmark, March 10, 2021 ·Two posters featuring innovative Genmab bispecific antibody programs…
SAN CARLOS, Calif., March 10, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
AFM24 preclinical in vivo data will be presented as a poster Data on AFM13 in…
CBL-B inhibitor NX-1607 mediates anti-tumor activity through both T cells and NK cellsPreclinical tumor models…
— Two presentations to highlight AO-176’s potential in lymphoma and T-ALL — BRISBANE, Calif. and ST….
ZUG, Switzerland and CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
SEATTLE, March 10, 2021 (GLOBE NEWSWIRE) — SEngine Precision Medicine, a precision oncology company revolutionizing…